BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 1699967)

  • 1. Growth of cultured human cerebral meningiomas is inhibited by dopaminergic agents. Presence of high affinity dopamine-D1 receptors.
    Schrell UM; Fahlbusch R; Adams EF; Nomikos P; Reif M
    J Clin Endocrinol Metab; 1990 Dec; 71(6):1669-71. PubMed ID: 1699967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Presence of dopamine D1 receptors and absence of dopamine D2 receptors in human cerebral meningioma tissue.
    Schrell UM; Nomikos P; Fahlbusch R
    J Neurosurg; 1992 Aug; 77(2):288-94. PubMed ID: 1385626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solubilization and reconstitution of dopamine D1 receptor from bovine striatal membranes: effects of agonist and antagonist pretreatment.
    Srivastava LK; Ross GM; Bajwa SB; Mishra RK
    Neurochem Res; 1990 Jun; 15(6):647-57. PubMed ID: 1977093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical and functional evidence for the presence of dopamine D1 receptors in the bovine ciliary body.
    Lograno MD; Daniele E; Govoni S
    Exp Eye Res; 1990 Nov; 51(5):495-501. PubMed ID: 1979033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Agonist-induced desensitization of D1-dopamine receptors linked to adenylyl cyclase activity in cultured NS20Y neuroblastoma cells.
    Barton AC; Sibley DR
    Mol Pharmacol; 1990 Oct; 38(4):531-41. PubMed ID: 1978240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoradiographic localization of D1 and D2 dopamine binding sites in the human retina.
    Denis P; Elena PP; Nordmann JP; Saraux H; Lapalus P
    Neurosci Lett; 1990 Aug; 116(1-2):81-6. PubMed ID: 2147983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine D1 receptor involvement in the discriminative-stimulus effects of SKF 81297 in squirrel monkeys.
    Rosenzweig-Lipson S; Bergman J
    J Pharmacol Exp Ther; 1993 Nov; 267(2):765-75. PubMed ID: 7902432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta 1-adrenergic and dopamine (D1)-receptors coupled to adenylyl cyclase activation in GT1 gonadotropin-releasing hormone neurosecretory cells.
    Findell PR; Wong KH; Jackman JK; Daniels DV
    Endocrinology; 1993 Feb; 132(2):682-8. PubMed ID: 8093877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of the 5-HT1C receptor expressed in Xenopus oocytes by the benzazepines SCH 23390 and SKF 38393.
    Briggs CA; Pollock NJ; Frail DE; Paxson CL; Rakowski RF; Kang CH; Kebabian JW
    Br J Pharmacol; 1991 Dec; 104(4):1038-44. PubMed ID: 1687364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defective dopamine-1 receptor adenylate cyclase coupling in the proximal convoluted tubule from the spontaneously hypertensive rat.
    Kinoshita S; Sidhu A; Felder RA
    J Clin Invest; 1989 Dec; 84(6):1849-56. PubMed ID: 2574187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Agonist-induced desensitization of D2 dopamine receptors in human Y-79 retinoblastoma cells.
    Barton AC; Black LE; Sibley DR
    Mol Pharmacol; 1991 May; 39(5):650-8. PubMed ID: 1674585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Desensitization of D1 dopamine receptors down-regulates the Gs alpha subunit of G protein in SK-N-MC neuroblastoma cells.
    Gupta SK; Mishra RK
    J Mol Neurosci; 1993; 4(2):117-23. PubMed ID: 8105856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct demonstration of D1 dopamine receptors in the bovine parathyroid gland using the D1 selective antagonist [125I]-SCH 23982.
    Monsma FJ; Sibley DR
    Synapse; 1989; 3(3):193-9. PubMed ID: 2524116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of D1-like dopamine receptors on human blood platelets.
    De Keyser J; De Waele M; Convents A; Ebinger G; Vauquelin G
    Life Sci; 1988; 42(18):1797-806. PubMed ID: 2834619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the D1-dopamine agonists SKF-38393 and A-68930 in neonatal 6-hydroxydopamine-lesioned rats: behavioral effects and induction of c-fos-like immunoreactivity.
    Johnson KB; Criswell HE; Jensen KF; Simson PE; Mueller RA; Breese GR
    J Pharmacol Exp Ther; 1992 Aug; 262(2):855-65. PubMed ID: 1354257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopaminergic regulation of the GT1 gonadotropin-releasing hormone (GnRH) neuronal cell lines: stimulation of GnRH release via D1-receptors positively coupled to adenylate cyclase.
    Martínez de la Escalera G; Gallo F; Choi AL; Weiner RI
    Endocrinology; 1992 Dec; 131(6):2965-71. PubMed ID: 1280208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Agonist efficacy and the behavioral effects of dopamine D1 receptor ligands: drug interaction studies in squirrel monkeys.
    Bergman J; Spealman RD; Madras BK; Rosenzweig-Lipson S
    J Pharmacol Exp Ther; 1996 Mar; 276(3):942-50. PubMed ID: 8786574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the central and renal dopamine-1 receptor.
    Sidhu A; Felder RA; Jose PA; Fishman PH
    Am J Hypertens; 1990 Jun; 3(6 Pt 2):37S-39S. PubMed ID: 1974441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and characterization of D1 and D2 dopamine receptors in cultured neuroblastoma and retinoblastoma clonal cell lines.
    Monsma FJ; Brassard DL; Sibley DR
    Brain Res; 1989 Jul; 492(1-2):314-24. PubMed ID: 2665904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of D1-dopamine receptor in chicken embryo retina with [125I]SCH 23982.
    Agui T; Chase TN; Kebabian JW
    Brain Res; 1988 Jun; 452(1-2):49-56. PubMed ID: 2969765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.